Search Results 581-590 of 12909 for Acute angle-closure glaucoma
This phase II trial studies how well midostaurin and decitabine work in treating older patients with newly diagnosed acute myeloid leukemia and fms-related ...
Participation eligibility · Previous posterior spinal surgery. · Systemic corticosteroid use. · Long-term anticoagulation treatment. · Diagnosis of diabetes ...
Knuttinen MG, Xie K, Jani A, Palumbo A, Carrillo T, Mar W. Pelvic venous insufficiency: imaging diagnosis, treatment approaches, and therapeutic issues. AJR Am ...
The safety and effectiveness of TheraSphere will be evaluated in patients with unresectable hepatocellular carcinoma in whom treatment with standard-of-care ...
The purpose of this study is to perform independent analysis of optimal synovial fluid diagnostic cutoffs for acute periprosthetic joint infection of the knee.
The Hospital Experiences to Advance Goals and Outcomes Network (HEXAGON) studies symptoms, comorbidities & outcomes of patients hospitalized for COVID-19 at ...
intravitreal aflibercept (2.0 mg) every 4 weeks. SCORE2 aims to determine if bevacizumab is non-inferior to aflibercept for the treatment of macular edema ...
By condition, treatment or drug name. Search tips ... Endoscopically visible scarring by any cause of the intended treatment zone ... Closed for enrollment ...
About this study. To determine the effectiveness of the ARTISAN Aphakia lens in the treatment of aphakia and to precisely define the associated risks and, ...
Mayo Clinic is the No. 1 hospital in the world., with campuses in Arizona, Florida, and Minnesota.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Mayo Clinic researchers drive discoveries that improve detection, diagnosis and treatment. Your quick message to them means so much.